Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445313 · ClinicalTrials.gov registry record
Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device
A clinical trial, sponsored by Doheny Image Reading Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT02445313: Completed study, sponsored by Doheny Image Reading Center.
NCT02445313 is a clinical trial that has completed, run by Doheny Image Reading Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02445313 has completed, sponsored by Doheny Image Reading Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.
Interventions
- DEVICE Nidek MP-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-02-12 |
What the finished NCT02445313 record still lists
NCT02445313 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Nidek MP-3 is the first listed.
NCT02445313 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02445313 about?
NCT02445313 is a clinical study titled "Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device". The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participan...
What is the current status of trial NCT02445313?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-06. Estimated completion is 2019-02-12.
What interventions are being tested in trial NCT02445313?
The interventions under investigation include: Nidek MP-3 (DEVICE).
Who is sponsoring clinical trial NCT02445313?
This trial is sponsored by Doheny Image Reading Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia